https://www.selleckchem.com/pr....oducts/iacs-010759-i
BV) status, pathology type, Ann-Arbor stage, and chemotherapy regimen were not significantly associated with survival. At the end of the study, 48.5% of patients achieved complete remission and the allograft survived in 84.8%. Conclusions In this retrospective study of very-late onset PTLD, we identified factors associated with survival different from early and late PTLD. These factors should be considered during the treatment of this subgroup of PTLD patients. Copyright © 2020, Bishnoi et al.Objectives To evaluate resear
Like
Comment
Share
